Recorded Webinar from November 15, 2018
Please join Fitch, Even, Tabin & Flannery LLP for a free webinar, “FRAND Licensing: Recent International Developments,” on Thursday, November 15, 2018, at 9:00 am PST / 10:00 am MST / 11:00 am CST / 12 noon EST.
Understanding the latest developments in FRAND licensing is essential to developing appropriate strategies for licensing standard essential patents (SEPs), both as licensor and licensee.
During this webinar, we will provide an overview of recent developments in FRAND licensing as a process and as a result, including a discussion of the following:
- Guidelines published in Europe, China, and Japan for licensing of SEPs
- Key decisions from the U.S., the UK, and China regarding how to determine FRAND terms and conditions, including
- Unwired Planet v. Huawei (UK)
- TCL v. Ericsson (US)
- Huawei v. Samsung (CN)
In addition, we will address these topics:
- Who holds the FRAND burden of proof
- What it means to be a willing licensee
- Jurisdiction for deciding FRAND disputes
- The appropriateness of confidentiality agreements
Our speaker will be Fitch Even senior licensing specialist and patent analyst Curtis S. Dodd. With 20 years of industry experience, Curt is a veteran of patent valuation, monetization, enforcement, and portfolio management in the telecommunications and consumer electronics spaces.
A recording of this webinar is available through November 14, 2019.
IP Alert | Federal Circuit Finds Claims Containing Natural Product Are Not Directed to a Judicial ExceptionMarch 20, 2019
On March 15, in Natural Alternatives Int'l. v. Creative Compounds, the Federal Circuit rejected a "law of nature" challenge to claims to a dietary supplement containing a naturally occurring amino acid and a method for treatment of a patient using the dietary supplement. Read more
IP Alert | USPTO Gives Patent Owners New Claim Amendment Options in AIA TrialsMarch 19, 2019
On March 15, the USPTO initiated a new pilot program for motions to amend filed during America Invents Act trial proceedings before the Patent Trial and Appeal Board. Read more